CVS Health Corporation (CVS)
CVS Health's Discounted Buying Opportunity Is Here - Robust Fundamentals And Secure Dividends
Proposed flat reimbursement rates for Medicare Advantage pressure recovery prospects, with CVS likely to suffer enrollment declines from the higher premiums through FY2027. Despite so, their diversified healthcare segments are likely to support their sustainable operations, aided by the potentially healthier membership base at higher rates. Thanks to the industry-wide pessimism, CVS is now undervalued at FWD P/E of 9.97x and 3Y PEG of 0.85x, with it triggering a bull-case PT of $83.60.
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note
CVS Health (CVS) concluded the recent trading session at $72.8, signifying a +2.12% move from its prior day's close.
Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
In the most recent trading session, CVS Health (CVS) closed at $74.81, indicating a -1.36% shift from the previous trading day.
California Public Employees Retirement System Has $175.91 Million Stake in CVS Health Corporation $CVS
California Public Employees Retirement System increased its stake in CVS Health Corporation (NYSE: CVS) by 5.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,333,350 shares of the pharmacy operator's stock after purchasing an additional 123,846 shares during the
Ameriprise Financial Inc. Acquires 592,575 Shares of CVS Health Corporation $CVS
Ameriprise Financial Inc. grew its holdings in shares of CVS Health Corporation (NYSE: CVS) by 7.5% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 8,448,420 shares of the pharmacy operator's stock after buying an additional 592,575 shares during the period. Ameriprise Financial Inc.
1,174,797 Shares in CVS Health Corporation $CVS Bought by 8 Knots Management LLC
8 Knots Management LLC purchased a new stake in CVS Health Corporation (NYSE: CVS) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 1,174,797 shares of the pharmacy operator's stock, valued at approximately $88,568,000. CVS Health makes up approximately 10.0% of 8 Knots
Callodine Capital Management LP Cuts Holdings in CVS Health Corporation $CVS
Callodine Capital Management LP lowered its stake in CVS Health Corporation (NYSE: CVS) by 39.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 313,427 shares of the pharmacy operator's stock after selling 204,573 shares during the period. CVS Health
Why Is CVS Health (CVS) Down 1.7% Since Last Earnings Report?
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
CVS Health Corporation (CVS) Presents at Leerink Global Healthcare Conference 2026 Transcript
CVS Health Corporation (CVS) Presents at Leerink Global Healthcare Conference 2026 Transcript
CVS Health: Stop Catastrophizing, Start Believing - Here's Why
CVS Health Corporation is rated a Buy, with a bullish outlook for 2026–2027 driven by margin recovery and undervalued valuation metrics. CVS trades at attractive forward P/S (~0.25x) and P/E (~13x), with potential for >50% share price upside if Medicare Advantage margins recover. 2026 guidance projects improved Medical Benefit Ratio, rising GAAP EPS ($6.04), and margin expansion across all divisions despite flat revenues.
